← Back to Clinical Trials
Recruiting NCT05743699

NCT05743699 Adaptation and Evaluation of Bright Horizons

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05743699
Status Recruiting
Phase
Sponsor Johns Hopkins Bloomberg School of Public Health
Condition Alcohol Abuse
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2025-07-17
Primary Completion 2027-01-31

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 24 Years
Study Type INTERVENTIONAL
Interventions
Bright HorizonsCase Management

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2025-07-17 with a primary completion date of 2027-01-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will test if a program called 'Bright Horizons' is effective at reducing binge substance use among adolescents. Bright Horizons is a culturally adapted intervention developed and tested through a partnership between The White Mountain Apache Tribe and Johns Hopkins University. Bright Horizons is a brief intervention that teaches emotion regulation, coping skills, and problem solving. The intervention also uses goal setting to reduce alcohol and other substance use and to connect to individuals with treatment.

Eligibility Criteria

Inclusion Criteria: * Aged 10-24 * Confirmed binge alcohol use event reported to the surveillance system within 90 days * Self identify as Native American * Reside on or near the Fort Apache Indian Reservation * Have parental or legal guardian consent/provide youth assent Exclusion Criteria: * Unstable and severe medical, psychiatric or drug use problems that necessitates inpatient treatment * Acute suicidal or homicidal ideation requiring immediate intervention * Recent and severe stressful life events such as physical or sexual abuse, or violent crime victimization that requires specific and high intensity interventions or out of home placement * Doesn't speak English * Severally visually impaired

Contact & Investigator

Central Contact

Mary Cwik, PhD

✉ mcwik1@jhu.edu

📞 410-955-6931

Principal Investigator

Mary Cwik, PhD

PRINCIPAL INVESTIGATOR

Johns Hopkins Bloomberg School of Public Health

Frequently Asked Questions

Who can join the NCT05743699 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 24 Years, studying Alcohol Abuse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05743699 currently recruiting?

Yes, NCT05743699 is actively recruiting participants. Contact the research team at mcwik1@jhu.edu for enrollment information.

Where is the NCT05743699 trial being conducted?

This trial is being conducted at Whiteriver, United States.

Who is sponsoring the NCT05743699 clinical trial?

NCT05743699 is sponsored by Johns Hopkins Bloomberg School of Public Health. The principal investigator is Mary Cwik, PhD at Johns Hopkins Bloomberg School of Public Health. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology